Navigation Links
CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding
Date:10/27/2010

WOBURN, Mass., Oct. 27 /PRNewswire/ -- CutisPharma, Inc. today announced that it has received approval from the United States Patent and Trademark Office for its patent (US 7,815,929) regarding a method for the preparation, storage and dispensing of compounded suppositories.

"By its very nature, the process of compounding suppositories is cumbersome, time-consuming and in general, without adequate compensation," said Dr. Indu Muni, founder, chairman, and CEO of CutisPharma, Inc. "Our container (suppository mold) and the method for suppository-compounding is user-friendly and time saving for a pharmacy. Our suppository mold is also customer friendly because the take-home molds are especially designed to not only maintain the integrity of each suppository once compounded, but also provide convenient patient dispensing," he added.

The patented container is currently used in CutisPharma's FIRST® Progesterone Vaginal Suppository Unit-of-Use Prescription Compounding Kit product line which includes FIRST® - Progesterone VGS 25, 50, 100, 200 and 400 representing various strengths (mg.).  The kits are made for a single patient and include pre-weighed progesterone, and suppository base, and a disposable container/mold for preparation, storage, and dispensing of the suppositories. A single NDC number assigned for the entire kit aids the third party reimbursement process, reduces audit- related adjustments, and the use of these FIRST® kits facilitates compliance with USP Chapter <795>.

CutisPharma estimates that over 1.5 million progesterone suppository prescriptions are written in the U.S. annually, representing a potential of nearly $100 million at the retail level. The Kit allows a pharmacy an easy entry into this market.  The Company is experiencing a steady conversion from the conventional way to the FIRST® - way.

FIRST® products save dispensing time, are easy to use, and can be compounded by the pharmacist while the patient waits increasing customer satisfaction.  Using FIRST® VGS kits, the pharmacist can compound a prescription for 30 vaginal suppositories 4 to 5 times faster than those prepared by the traditional method using a metal suppository mold or polystyrene shells.  This is based on a study that was conducted by researchers at the Massachusetts College of Pharmacy and Health Science and published in the International Journal of Pharmaceutical Compounding in July/August 2009.

About CutisPharma

CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on developing and commercializing value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry.  Product line and development efforts, initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 8 million currently compounded prescriptions, by offering FIRST®  Unit-of-Use Prescription Compounding Kits.  Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.  

For more information please visit our website at www.cutispharma.com


'/>"/>
SOURCE CutisPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction
2. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
3. Onyx Pharmaceuticals Announces Third Quarter 2010 Financial Results Teleconference and Webcast
4. Baxa Corporation Announces 2011 Course Schedule for its STAR Center® Training Facility
5. Baltimores Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
6. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
7. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
8. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
9. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
10. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
11. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 2016 Research and ... Acute Ischemic Stroke Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Stroke Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Ischemic Stroke epidemiology, Acute ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... , May 4, 2016 ... across 154 pages, profiling 09 key companies and ... a professional and in-depth study on the current ... basic overview of the industry including definitions, classifications, ... market analysis is provided for the international market ...
Breaking Medicine Technology:
(Date:5/5/2016)... Lehi, Utah (PRWEB) , ... May 05, 2016 ... ... emergency life support certifications, is pleased to announce its new referral program, giving ... , “Healthcare is a tight-knit community, and we know many professionals share ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... ctellez(at)msnva.org , The Medical Society of Northern Virginia, Announces DoctorsTelemed?, A ... The Medical Society of Northern Virginia (MSNVA) launches DoctorsTelemed?, a telemedicine solution ...
(Date:5/5/2016)... ... 2016 , ... In the midst of making plans for the popular Mexican ... planning a safe way of getting home after the festivities. Every year, millions of ... lead to drunk drivers on the roads who become involved in fatal car accidents. ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... 1,000,000 mark for blood and service orders. Blood suppliers and their hospitals ... , “BloodHub serves 13,000 active users across 2,100 hospitals who use our ...
(Date:5/4/2016)... MD (PRWEB) , ... May 05, 2016 , ... The ... directions. High impact injuries like falls, or traffic accidents can cause the talus bone ... (AVN)—the death of the bone. In a first-of-its-kind procedure using 3D printing technology, internationally ...
Breaking Medicine News(10 mins):